FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * O'Loughlin Senan 2. Date of Event Requiring Statement (Month/Day/Year) 06/22/2026 3. Issuer Name and Ticker or Trading Symbol REINSURANCE GROUP OF AMERICA INC [RGA] (Last) (First) (Middle) 16600 SWINGLEY RIDGE ROAD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Executive Vice President 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) CHESTERFIELD, MO 63017 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 2,967.412 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit - March 2026	(1)	(1)	Common Stock	539	$0(2)	D
Restricted Share Unit - March 2025	(3)	(3)	Common Stock	291	$0(2)	D
Restricted Share Unit - March 2024	(4)	(4)	Common Stock	142	$0(2)	D
Stock Appreciation Right (right to purchase) 2026	(1)	03/19/2036	Common Stock	1,556	$200.5	D
Stock Appreciation Right (right to purchase) 2025	(3)	03/06/2035	Common Stock	1,190	$193	D
Stock Appreciation Right (right to purchase) 2024	(4)	03/15/2034	Common Stock	1,081	$185.28	D
Stock Appreciation Right (right to purchase) 2023	(5)	03/09/2033	Common Stock	964	$138.34	D
Stock Appreciation Right (right to purchase) 2022	(5)	03/22/2032	Common Stock	1,263	$106.53	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
O'Loughlin Senan 16600 SWINGLEY RIDGE ROAD CHESTERFIELD, MO 63017			Executive Vice President

Signatures

/s/ My Chi To, by Power of Attorney		07/02/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Stock appreciation rights and restricted share units settle in common stock, vest in 33 1/3% increments, beginning on the first anniversary date of the grant, and fully vest on March 19, 2029.
(2)	Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock upon vesting.
(3)	Stock appreciation rights and restricted share units settle in common stock, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2027.
(4)	Stock appreciation rights and restricted share units settle in common stock, vest in 33 and 1/3% increments over three years, and fully vest on December 31, 2026.
(5)	Stock appreciation rights settle in common stock and vest in 25% increments, over four years, beginning on December 31 of the year of grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.